A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems

NCT06272058 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Healthy
Liver Diseases

Interventions

DRUG: Avenciguat (BI 685509)

Sponsor

Boehringer Ingelheim